Explain How New ORAL Semaglutide Stacks Up for Weight Loss Patients are asking about Rx semaglutide tablets (Wegovy), the first ORAL GLP-1 agonist FDA approved for obesity and overweight... Resources Chart: GLP-1 and GIP/GLP-1 Receptor Agonist Interactive Comparison Chart Chart: Comparison of Weight Loss Products
Be Prepared With Guidance About Childhood Immunizations Changes to the CDC childhood vaccine schedule are causing confusion...
Set the Record Straight With Menopausal Hormone Therapy Patients will ask you about menopausal hormone therapy (MHT)...
Clear the Air With New COPD Guidelines Updated COPD guidelines suggest starting daily inhalers sooner...
